🔥 Breakout ↑ Rising
Business
Moderna and Merck say mRNA cancer vaccine succeeded in late-stage melanoma trial
Moderna shares surged following trial results for a personalized mRNA melanoma vaccine developed with Merck.
1 independently sourced, verified news trends involving Moderna and Merck.
This hub is built from stories supported by at least four independent sources and accepted by Newsylist's verification pass. Qualifying coverage spans 1 news category, from Aug 19, 2026 through Aug 19, 2026.
Open any card for the source list, timeline and coverage-velocity evidence. Raw detections and extractive-only records are excluded from this page.
Moderna shares surged following trial results for a personalized mRNA melanoma vaccine developed with Merck.